Analyze Diet
Biomedical chromatography : BMC2009; 24(7); 744-751; doi: 10.1002/bmc.1358

In vitro and in vivo studies of androst-4-ene-3,6,17-trione in horses by gas chromatography-mass spectrometry.

Abstract: This paper describes the application of gas chromatography-mass spectrometry (GC-MS) for in vitro and in vivo studies of 6-OXO in horses, with a special aim to identify the most appropriate target metabolite to be monitored for controlling the administration of 6-OXO in racehorses. In vitro studies of 6-OXO were performed using horse liver microsomes. The major biotransformation observed was reduction of one keto group at the C3 or C6 positions. Three in vitro metabolites, namely 6alpha-hydroxyandrost-4-ene-3,17-dione (M1), 3alpha-hydroxyandrost-4-ene-6,17-dione (M2a) and 3beta-hydroxyandrost-4-ene-6,17-dione (M2b) were identified. For the in vivo studies, two thoroughbred geldings were each administered orally with 500 mg of androst-4-ene-3,6,17-trione (5 capsules of 6-OXO((R))) by stomach tubing. The results revealed that 6-OXO was extensively metabolized. The three in vitro metabolites (M1, M2a and M2b) identified earlier were all detected in post-administration urine samples. In addition, seven other urinary metabolites, derived from a further reduction of either one of the remaining keto groups or one of the remaining keto groups and the olefin group, were identified. These metabolites included 6alpha,17beta-dihydroxyandrost-4-en-3-one (M3a), 6,17-dihydroxyandrost-4-en-3-one (M3b and M3c), 3beta,6beta-dihydroxyandrost-4-en-17-one (M4a), 3,6-dihydroxyandrost-4-en-17-one (M4b), 3,6-dihydroxyandrostan-17-one (M5) and 3,17-dihydroxyandrostan-6-one (M6). The longest detection time observed in urine was up to 46 h for the M6 metabolite. For blood samples, the peak 6-OXO plasma concentration was observed 1 h post administration. Plasma 6-OXO decreased rapidly and was not detectable 12 h post administration.
Publication Date: 2009-11-03 PubMed ID: 19882746DOI: 10.1002/bmc.1358Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Evaluation Study
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The article discusses the use of Gas Chromatography-Mass Spectrometry (GC-MS) for studying the metabolism of 6-OXO in horses, in order to find the best detection method for its regulation in racehorses.

Research Methodology

  • The study was conducted both in vitro (in a controlled laboratory environment) and in vivo (within living organisms). The in vitro study was done using horse liver microsomes to simulate the metabolism process.
  • For the in vivo study, two thoroughbred geldings (castrated male horses) were orally administered with 500 mg of 6-OXO (androst-4-ene-3,6,17-trione). The administration was done by stomach tubing, a method used often for horses.

In Vitro Findings

  • The primary biotransformation observed was the reduction of a keto group at the C3 or C6 positions.
  • Three in vitro metabolites were identified, named M1, M2a, and M2b, revealing the biotransformation process of 6-OXO in a controlled environment.

In Vivo Findings

  • The results of the in vivo study showed that 6-OXO was extensively metabolized within the horses. The three metabolites identified in the in vitro study were all found in urine samples taken after administration of 6-OXO.
  • Additionally, seven other urinary metabolites were detected, which were a result of further reduction of the remaining keto group or a reaction with the olefin group. These were named M3a, M3b, M3c, M4a, M4b, M5, and M6.
  • For the detection of the metabolite in the horses’ system, M6 had the longest detection time in urine, up to 46 hours.

Plasma Concentration Findings

  • During the study, the peak 6-OXO plasma concentration was noted 1 hour post administration.
  • The plasma concentration of 6-OXO decreased rapidly and was undetectable 12 hours after administration. This indicates the speed and efficiency at which horses metabolize the substance.

In summary, the researchers have identified the key metabolites to track for monitoring the administration of 6-OXO in horses, which is crucial for doping controls in horse racing. The findings indicate that monitoring urinary metabolites (particularly M6) is a reliable method, considering their longer detection window.

Cite This Article

APA
Leung GN, Tang FP, Wan TS, Wong CH, Lam KK, Stewart BD. (2009). In vitro and in vivo studies of androst-4-ene-3,6,17-trione in horses by gas chromatography-mass spectrometry. Biomed Chromatogr, 24(7), 744-751. https://doi.org/10.1002/bmc.1358

Publication

ISSN: 1099-0801
NlmUniqueID: 8610241
Country: England
Language: English
Volume: 24
Issue: 7
Pages: 744-751

Researcher Affiliations

Leung, Gary N W
  • Racing Laboratory, The Hong Kong Jockey Club, Sha Tin Racecourse, Sha Tin, N.T., Hong Kong, China. gary.nw.leung@hkjc.org.hk
Tang, Francis P W
    Wan, Terence S M
      Wong, Colton H F
        Lam, Kenneth K H
          Stewart, Brian D

            MeSH Terms

            • Anabolic Agents / analysis
            • Anabolic Agents / metabolism
            • Anabolic Agents / urine
            • Androstenes / analysis
            • Androstenes / metabolism
            • Androstenes / urine
            • Animals
            • Doping in Sports
            • Gas Chromatography-Mass Spectrometry / methods
            • Horses / urine
            • Microsomes, Liver / chemistry
            • Microsomes, Liver / metabolism

            Citations

            This article has been cited 0 times.